Ashland (NYSE: ASH) reported Q1 EPS of $0.14, $0.01 worse than the analyst estimate of $0.15. Revenue for the quarter came in at $576 million versus the consensus estimate of $584.98 million.

GUIDANCE:

Ashland sees Q2 2019 EPS of $0.80-$0.90, versus the consensus of $0.83.

"In summary, our reaffirmed outlook for fiscal 2019 reflects continued progress toward the long-term financial targets shared at our Investor Day in 2017. This includes mid-single-digit growth in Specialty Ingredients' adjusted EBITDA plus $20 million of savings from the ongoing cost reduction program. Together, the actions we have taken to improve our business are driving strong earnings and margin growth while also positioning Ashland to fulfill our vision of becoming the premier specialty chemicals company," Wulfsohn said.

For earnings history and earnings-related data on Ashland (ASH) click here.